Results from the MONITOR HF trial, published in The Lancet, showedAbbott's CardioMEMS implantable hemodynamic monitor can improve heart failure patients’ quality of life.
The trial, sponsored by the Dutch Ministry of Health, Health Care Institute (Zorginstituut), and Abbott, randomized 348 heart-failure patients in...